1. Evaluation of pyridoacridine alkaloids in a zebrafish phenotypic assay.
- Author
-
Wei X, Bugni TS, Harper MK, Sandoval IT, Manos EJ, Swift J, Van Wagoner RM, Jones DA, and Ireland CM
- Subjects
- Acridines isolation & purification, Animals, Cytotoxins chemistry, Cytotoxins isolation & purification, Cytotoxins toxicity, Embryo, Nonmammalian drug effects, Embryo, Nonmammalian pathology, Embryonic Development drug effects, In Situ Hybridization, Notochord drug effects, Notochord pathology, Pacific Ocean, Palau, Phenanthrolines isolation & purification, Somites drug effects, Somites pathology, Teratogens isolation & purification, Tissue Extracts chemistry, Toxicity Tests, Xestospongia chemistry, Zebrafish, Acridines chemistry, Acridines toxicity, Drug Discovery methods, Phenanthrolines chemistry, Phenanthrolines toxicity, Teratogens chemistry, Teratogens toxicity
- Abstract
Three new minor components, the pyridoacridine alkaloids 1-hydroxy-deoxyamphimedine (1), 3-hydroxy-deoxyamphimedine (2), debromopetrosamine (3), and three known compounds, amphimedine (4), neoamphimedine (5) and deoxyamphimedine (6), have been isolated from the sponge Xestospongia cf. carbonaria, collected in Palau. Structures were assigned on the basis of extensive 1D and 2D NMR studies as well as analysis by HRESIMS. Compounds 1-6 were evaluated in a zebrafish phenotype-based assay. Amphimedine (4) was the only compound that caused a phenotype in zebrafish embryos at 30 muM. No phenotype other than death was observed for compounds 1-3, 5, 6.
- Published
- 2010
- Full Text
- View/download PDF